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Abstract
Introduction: The melanocortin system plays an important role in energy homeostasis. Mice genetically deficient in the
melanocortin-3 receptor gene have a normal body weight with increased body fat, mild hypophagia compared to wild-type
mice. In humans, Thr6Lys and Val81Ile variants of the melanocortin-3 receptor gene (MC3R) have been associated with
childhood obesity, higher BMI Z-score and elevated body fat percentage compared to non-carriers. The aim of this study is
to assess the association in adults between allelic variants of MC3R with weight loss induced by energy-restricted diets.
Subjects and Methods: This research is based on the NUGENOB study, a trial conducted to assess weight loss during a 10-
week dietary intervention involving two different hypo-energetic (high-fat and low-fat) diets. A total of 760 obese patients
were genotyped for 10 single nucleotide polymorphisms covering the single exon of MC3R gene and its flanking regions,
including the missense variants Thr6Lys and Val81Ile. Linear mixed models and haplotype-based analysis were carried out to
assess the potential association between genetic polymorphisms and differential weight loss, fat mass loss, waist change
and resting energy expenditure changes.
Results: No differences in drop-out rate were found by MC3R genotypes. The rs6014646 polymorphism was significantly
associated with weight loss using co-dominant (p=0.04) and dominant models (p=0.03). These p-values were not
statistically significant after strict control for multiple testing. Haplotype-based multivariate analysis using permutations
showed that rs3827103–rs1543873 (p=0.06), rs6014646–rs6024730 (p=0.05) and rs3746619–rs3827103 (p=0.10) displayed
near-statistical significant results in relation to weight loss. No other significant associations or gene*diet interactions were
detected for weight loss, fat mass loss, waist change and resting energy expenditure changes.
Conclusion: The study provided overall sufficient evidence to support that there is no major effect of genetic variants of
MC3R and differential weight loss after a 10-week dietary intervention with hypo-energetic diets in obese Europeans.
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Introduction
Obesity and hyperphagia displayed by animal models with
genetic alterations in the leptin-melanocortin system outline the
importance of these biological pathways in body weight regulation
[1]. Genetic ablation of melanocortin 4 receptor gene in mice
produces hyperphagia and obesity [2] while rare mutations in the
corresponding human MC4R are a cause of severe childhood
obesity [3]. Contrary to the effects observed in mice Mc4r gene,
the Mc3r2/2 mouse shows an unique phenotype characterized
by higher percentage of body fat without increased body weight,
mild hypophagia, higher energy efficiency, reduced locomotor
activity, hyperleptinemia and reduced linear growth compared
with the Mc3r+/+ mouse [4,5]. Indeed, it has been reported that
mice with genetic disruption in both Mc3r and Mc4r are heavier
than Mc4r2/2 mice, indicating a possible non-redundant
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adiposity-related phenotypes [4].
Some linkage studies are concordant with the presence of a
susceptibility gene for human obesity at the melanocortin-3
receptor MC3R locus (gene ID:4159; 20q13.2-13.3) [6,7]. The
missense variants Thr6Lys (rs3746619) and Val81Ile (rs3827103)
of MC3R have been related with in vitro diminished functionality
and expression of the receptor, showing a significant association
with childhood obesity in a case-control study [8]. Additionally,
some mutations in MC3R have been proposed as a cause of human
monogenic obesity [9]. Genetic epidemiological studies have
reported different results regarding the association between
common MC3R variants and common forms of obesity [10–14].
Additionally, large genome-wide association studies have not been
able to substantiate associations between variants near the MC3R
locus and polygenic obesity [15]. In this context, there is published
evidence to support a role of the MC3R variants Thr6Lys and
Val81Ile in weight loss responses of obese children [16]. Herein,
we have used previously published data from the NUGENOB
study (http://www.nugenob.org) (Figure 1) [17] to assess the
association between genetic variants of MC3R with weight loss
induced by hypo-energetic low-fat/high-fat diets in obese
European adults.
Methods
Ethics Statement
The selection of participants was carried out in the frame of the
NUGENOB project (http://www.nugenob.org) [17], under the
approval of Ethical committees at each of the participating centers.
Volunteers were informed about the nature of the study, and
written consent was obtained prior to study participation. The
names of the ethics local committees were: Research Ethic
Committee of the University of Navarra, The Danish Research
Ethics Committee System, Medical ethics committee of the
Maastricht University, Ethics Committee of the Hotel-Dieu
Hospital, University of Nottingham Medical School Ethics
Committee, The Swedish National Council on Medical Ethics
and Ethics Commission of the medical School of Toulouse.
Study Design and Subjects
The NUGENOB trial consisted in a 10-week dietary interven-
tion with two types of hypo-energetic (2600 kcal/day) diets with a
targeted fat energy of 20%–25% (low-fat diet, 15% energy from
protein and 60–65 from carbohydrates) or 40%–45% (high-fat
diet, with 15% energy from protein and 40–45 from carbohy-
drates) in obese patients [17]. The study involved 771 European
obese adult subjects from eight recruiting centres of seven
countries: United Kingdom (Nottingham), the Netherlands
(Maastricht), France (Paris and Toulouse), Spain (Pamplona),
Czech Republic (Prague), Sweden (Stockholm), and Denmark
(Copenhagen). Obese patients participated in this randomised,
parallel, two-arm, open-label multi-centre trial to assess weight
loss. Obese patients were allocated to the two hypo-energetic diets
by stratified block randomization using computer list generated at
the coordinating centre.
The participants were 570 women and 192 men, aged 20–50
years and overweight or obese, with a high percentage (94.7%) of
subjects with obesity, defined as having Body Mass Index (BMI)
greater than or equal to 30 Kg/m
2 (Median BMI=34.7 Kg/m
2;
Mean BMI=35.6 Kg/m
2; Standard deviation BMI=4.9 Kg/
m
2). Exclusion criteria were: subjects with changes of more than
3 Kg within the three months previous to the trial, clinically
diagnosed hypertension, diabetes or hyperlipidemia treated by
drugs, untreated thyroid disease, surgically or drug-treated obesity,
pregnancy, or alcohol or drug abuse.
Dietary Intervention
All the details regarding the dietary intervention are described in
Petersen et al. [17] and in the web page http://www.nugenob.org.
Figure 1. Flow chart of the NUGENOB trial and genotyping success of MC3R variants. Legend to Figure 1: weight loss is expressed as
mean 6 standard deviation.
doi:10.1371/journal.pone.0019934.g001
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underwent a thorough standardized clinical and physiological
examination described in Standard Operational Procedures applied
inallparticipating centers.Thetargetmacronutrient compositionof
the two diets was: Low-fat (LF) diet (20%–25% of total energy from
fat, 15% from protein and 60%–65% from carbohydrate) and
High-fat (HF) diet (40%–45% of total energy from fat, 15% from
protein, and 40%–45% from carbohydrate). Both diets were
designed to provide 600 kcal/d fewer than the individually
estimated energy requirements, which was calculated based on
the estimation of the measured pre-treatment resting metabolic rate
multiplied by a physical activity factor of 1.3. The dietary
instructions were designed to minimize possible differences between
the two diets in other components such as source and type of fat,
Figure 2. MC3R polymorphisms genotyped in this study and linkage disequilibrium (r
2) measures.
doi:10.1371/journal.pone.0019934.g002
Table 1. Basic statistical analysis of MC3R variants.
SNP Position 20q
Minor Allele
Frequency
Percentage of
Genotyped P-value HWE
P-value for differences
among study centres
rs6024728 54252413 0.18 99.1 0.098 0.35
rs6014646 54253186 0.32 97.2 0.132 0.10
rs6024730 54254196 0.18 98.3 0.158 0.16
rs6024731 54254823 0.25 98.6 0.162 0.13
rs11697509 54256257 0.14 98.7 0.911 0.26
rs6127698 54256823 0.49 99.3 0.482 0.75
rs3746619 54257212 0.09 98.9 0.172 0.39
rs3827103 54257436 0.08 99.6 0.206 0.50
rs1543873 54261736 0.11 99.6 0.298 0.39
rs6099058 54263016 0.38 99.7 0.008 0.66
doi:10.1371/journal.pone.0019934.t001
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vegetables, and in meal frequency patterns, while taking local
customs into account as appropriate. Participants were requested to
abstain from alcohol consumption during the trial. The dietary
instructions were reinforced and monitored and participants were
weighed weekly. Participants were advised to follow their habitual
activity patterns throughout the dietary intervention period.
Anthropometry, Body Composition and Resting Energy
Expenditure
Before randomization and after completion of the 10-week
intervention, participants underwent a clinical investigation
protocol. Measurements of weight and height were carried out
with a calibrated set of stadiometers and scales, in light indoor
clothes and without shoes. Waist circumference was measured
while the participants were wearing only nonrestrictive underwear.
The mean of three measurements was recorded for each
anthropometric variable. Fat mass was assessed by multifrequency
bioimpedance (QuadScan 4000; Bodystat, Isle of Man, British
Isles). At the beginning of the intervention, Resting Energy
Expenditure (REE) was measured in all participants by indirect
calorimetry using open circuit ventilated hood systems and pooled
from different centers through a validation program. After the 10-
week intervention, REE was again measured in 440 participants
(345 women and 95 men) of the individuals who completed the
intervention. REE (kcal/24 h.) was calculated with the equation of
Weir [18].
SNP Selection and Genotyping
The single exon of MC3R (geneID 4159, 20q13; 1083 base
pairs) and its flanking region (5 kb upstream and downstream) was
evaluated for the selection of SNPs (MC3R sequences:
NC_000020.9; NT_011362.9; NM_019888.2; NP_063941.2).
The Tagger program within the HapMap database (http://
www.hapmap.org) was used to select the most appropriate set of
markers for this study under the criteria of minor allele frequency
(MAF) 5% and r
2,0.8. After incorporating tagSNPs in the coding
region (rs3827103 and rs3746619), additional 8 markers were
selected: 6 SNPs located 5 kb upstream MC3R (rs6024728,
rs6014646, rs6024730, rs6024731, rs11697509 and rs6127698)
and 2 SNPs located 5 kb downstream of MC3R (rs1543873 and
rs6099058) (Figure 2).
Blood samples, drawing and processing, were performed
according to international guidelines for genetic studies. Geno-
typing was carried out by KBiosciences using their TaqMan allelic
discrimination assay (http://www.kbiosciences.com). Genotyping
success rate ranged from 99.1% (rs6024728) to 99.7% (rs6099058).
A total of 760 participants of the NUGENOB trial were genotyped
for MC3R allelic variants (Figure 1).
Statistical analyses
Descriptive summary statistics of the variables involved in the study
was carried out, including estimation of genotype/allele frequencies
and Hardy-Weinbergequilibrium(HWE) assessment. Disequilibrium
coefficients r
2 and D9 were computed as a measure of Linkage
Disequilibrium (LD) between pairs of SNPs. Logistic regression
ana ly s isw asu se dt oas se s stheas s o c i ati o nb e tw e e nd ro p - o u tr ate sw i th
genotypes and type of diet. Additional multivariate adjustment (BMI,
age, sex and centre) yielded essentially the same conclusion as non-
adjusted models.
The outcome variables assessed in this study were weight loss,
fat-mass loss, waist circumference changes and REE changes by
genotype after the intervention with hypo-caloric diets. Phenotype
changes were calculated by subtracting measurements carried out
immediately before randomization from measurements performed
after the completion of the trial. Linear mixed models were used
separately to assess changes for each outcome and for each SNP in
MC3R gene. Genotype codification was managed using the co-
dominant model in which the genotypes were coded as 0, 1 or 2
depending on the number of alternative alleles in the genotype.
Additionally, general models (genotypes as dummy variables with
the homozygous wild-type as reference) as well as dominant and
recessive models were fitted to the data. For weight loss, regression
analyses were carried out with type of hypo-energetic diet, gender,
age, age
2, initial weight, gender*initial weight, and centre of study
(random variable effect) as covariates. In models for changes in fat
mass, waist and REE, we controlled for respective baseline values,
an interaction term between gender and initial values for each
phenotype, as well as the type of hypo-energetic diet, gender, age,
age
2, and centre of study (random variable effect). Changes in
Table 2. Drop out according to MC3R genotypes and type of
diet.
Drop-out
Percentage
Per-allele OR
(95%CI)
P-value gene
*diet interaction
rs6024728 CC CA AA 1.1 (0.8–1.6) 0.69
High-fat 18.1 18.1 21.1
Low-fat 12.9 13.5 23.1
rs6014646 AA AT TT 1.1 (0.8–1.5) 0.10
High-fat 16.6 17.2 28.8
Low-fat 14.3 12.8 9.1
rs6024730 GG GA AA 1.0 (0.7–1.5) 0.24
High-fat 17.1 20.6 21.7
Low-fat 14.3 10.5 14.3
rs6024731 AA AG GG 1.1 (0.8–1.5) 0.17
High-fat 16.2 18.8 28.1
Low-fat 14.3 11.1 14.3
rs11697509 CC CG GG 1.3 (0.9–1.9) 0.36
High-fat 16.9 21.6 36.4
Low-fat 13.3 14.3 0
rs6127698 GG GT TT 0.8 (0.6–1.1) 0.31
High-fat 22.5 18.6 12.8
Low-fat 11.2 15.8 10.8
rs3746619 CC CA AA 1.3 (0.8–2.0) 0.92
High-fat 17.7 19.3 33.3
Low-fat 12.8 16.7 0
rs3827103 GG GA AA 1.4 (0.9–2.2) 0.77
High-fat 17.7 19.3 37.5
Low-fat 12.7 18.4 0
rs1543873 TT TG GG 1.3 (0.9–1.9) 0.92
High-fat 17.6 19.7 33.3
Low-fat 12.7 16.2 0
rs6099058 GG GA AA 1.2 (0.9–1.5) 0.54
High-fat 15.4 19.7 21.6
Low-fat 12.7 13.9 13.2
*Per-allele OR’s for drop-outs and MC3R genotypes were calculated using
logistic regression with the least frequent allele for each SNP coded a 0, 1 or 2
alleles (see statistical methods).
doi:10.1371/journal.pone.0019934.t002
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free mass. Gene*diet interactions between MC3R genotypes and
type of diet (low-fat and high-fat) were assessed in the context of
co-dominant models for each outcome variable using the
multivariate models described above. Haplotype-based association
analysis was carried out for weight loss using likelihood ratio tests
or permutations. Associations were adjusted by diet, initial weight,
age, age
2, gender and centre of study as covariates. Statistical
analyses were carried out with the programs R (v.2.8.1), STATA
11.0, HAPLOVIEW 4.1 and UNPHASED 3.1 [19].
As previously reported for statistical power calculations in the
NUGENOB trial [20], the least detectable weight loss of main
genetic effects ranged from 1.30–0.78 Kg for dominant models,
from 7.72–0.89 Kg for recessive models, and from 1.25–0.55 Kg
for additive co-dominant models (allele frequencies ranging from
0.05 to 0.5). Assuming an equal distribution of participants
between the diets, the least detectable effects on weight loss of
gene-diet interaction ranged from 2.49–1.07 Kg for additive co-
dominant models. These calculations were performed with the
assumptions of a statistical power of 0.80, a sample size of 642
individuals, and a mean weight loss of 6.8 Kg with a standard
deviation of 3.5 Kg (software QUANTO 1.0; http://hydra.usc.
edu/gxe).
Results
Allele/genotype frequencies for MC3R polymorphisms and p-
values for Hardy-Weinberg equilibrium are shown in Table 1.
Very high levels of LD in our sample (Figure 2) were found
between the two coding SNPs rs3746619 (Thr6Lys) and
rs3827103 (Val81Ile) of MC3R (D9=0.99; r
2=0.94). No differ-
ences were found in genotype frequencies by study centre using a
simple chi-square test. Genotype frequencies in the whole sample
were concordant with Hardy-Weinberg proportions except for
rs6099058 (Table 1). The degree of deviation was considered as
acceptable (expected and observed heterozygosity of 0.47 and 0.43
respectively) to keep rs6099058 in the subsequent analyses.
A total of 120 subjects of the successfully genotyped participants
(n=760; Figure 1) failed to complete the 10-week intervention
trial. Table 2 shows drop-out percentages according to MC3R
genotypes and type of diet. No significant differences in drop-out
were detected across MC3R genotypes, and there were no
evidences of gene-diet interactions.
The overall mean changes of weight, fat mass, waist
circumference and REE were 26.8 Kg, 25.3 Kg, 26.3 cm and
2109.9 kcal/24 h respectively. Table 3 shows the basic statistical
genetic analysis and the main results for MC3R genotypes and
weight loss and waist change. When assessing weight loss, the
T-allele of rs6014646 showed significant association to weight loss
using the co-dominant (p=0.04) and dominant (p=0.03) models.
Using the dominant model, carriers of the T allele in rs6014646
showed 20.55 Kg smaller weight loss (95% CI: 20.03 to 21.06)
compared to the AA genotype. The SNP rs6127698 achieved
statistical significance level (p=0.04) to weight loss only in the
recessive model. No other significant p-values for association were
found at the 0.05 level. Near-significant results were obtained for
rs1543873 using the general and dominant models (p=0.09 and
0.1 respectively). None of the p-values can be considered as
significant after controlling for multiple testing. As an example of
the magnitude of weight loss and its difference by MC3R
genotypes, Figure 3 shows crude weight loss by genotypes of the
missense variants rs3746619 (Thr6Lys) and rs3827103 (Val81Ile).
On the other hand, no gene*diet interaction terms were found to
be significant in the multivariate general model when assessing
weight loss response in relation to MC3R genotypes and the type of
diet (low-fat and high-fat) (Table 3). No significant associations or
gen-diet interactions were found in assessing changes in waist
during intervention. Table 4 shows the main results for MC3R
genotypes in relation to fat mass loss and REE changes. No
statistical genetic effects or gene*diet interactions were detected in
this analysis.
Haplotype-based multivariate analysis for weight loss using
sliding-window approach showed that rs3827103–rs1543873
(p=0.04), rs6014646–rs6024730 (p=0.06) and rs3746619–
rs3827103 (p=0.10) achieved statistical or near-statistical signif-
icant results in relation to weight loss. Permutation test (1000
simulations) yielded p-values of 0.06, 0.05 and 0.10, respectively,
for these three haplotypes.
Table 3. MC3R variants, weight loss and waist circumference change in the NUGENOB trial.
Per-allele* weight loss change (Kg) Per-allele* waist change (cm)
SNP
Beta
coefficient
Standard
error
P-value gene
effects
P-value gene
*diet interaction
Beta
coefficient
Standard
error
P-value
gene effects
P-value
gene*diet
interaction
rs6024728 0.23 0.23 0.33 0.89 0.01 0.30 0.96 0.47
rs6014646 20.39 0.19 0.04 0.48 20.29 0.26 0.27 0.84
rs6024730 20.24 0.23 0.30 0.57 20.18 0.31 0.56 0.39
rs6024731 20.34 0.21 0.10 0.72 20.27 0.28 0.33 0.76
rs11697509 20.27 0.27 0.33 0.20 0.04 0.37 0.92 0.05
rs6127698 0.25 0.18 0.15 0.81 0.23 0.23 0.32 0.62
rs3746619 20.24 0.32 0.45 0.81 0.02 0.43 0.97 0.68
rs3827103 20.03 0.34 0.92 0.90 0.22 0.45 0.63 0.72
rs1543873 20.47 0.29 0.11 0.42 20.07 0.39 0.85 0.26
rs6099058 20.15 0.18 0.41 0.80 20.17 0.24 0.48 0.16
*Per-allele changes were calculated using the number of the least frequent alleles for each SNP (coded a 0, 1 or 2 alleles) and under the co-dominant model adjusted for
covariates (see statistical methods).
doi:10.1371/journal.pone.0019934.t003
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Genotype-dependent response to energy-restricted diets is a
relevant topic in personalized nutrition [21], although the genetic
effects of known genetic variants on weight loss induced by hypo-
energetic diets remain poorly defined [22]. In spite of the
importance of the melanocortin system in energy balance [1,23–
24], no information was available on the effect of MC3R on
weight loss in obese adults submitted to hypo-energetic diets. In a
study involving 184 obese children, Santoro et al. [16] found that
rs3746619 (Thr6Lys) and rs3827103 (Val81Ile) of MC3R were
associated with a differential weight loss in response to a negative
energy balance in obese children (carriers of 6Lys and 81Ile alleles
showed higher resistance to weight loss than non-carriers). We
have also found in our study a trend for a greater resistance in
losing weight in 6Lys and 81Ile carriers, although without
achieving statistical significance. The missense variants Thr6Lys
and Val81Ile of MC3R are in strong linkage disequilibrium which
means that alleles 6Lys and 81Ile frequently occur in the same
haplotype [10–14,16]. The simultaneous occurrence of alternative
alleles in Thr6Lys and Val81Ile have been also associated in
previous studies with childhood obesity, energy intake, eating
behavior, substrate oxidation and first-phase insulin secretion
[8,10–14,25].
Research in mice is concordant with a role for Mc3r acting as
an inhibitory autoreceptor in Pomc neurons of the arcuate nucleus
[26]. According to this role, it has been shown that peripheral
administration of selective MC3R agonists stimulates feeding
[23,26–28]. However, it is unlikely that this inhibitory action in the
arcuate nucleus constitutes the predominant role of Mc3r in
energy homeostasis given that this receptor is also expressed in
multiple brain nuclei and peripheral tissues [29]. On the other
hand, it has been also shown that Mc3r is implicated in the
entrainment of food anticipatory behavior [30]. In addition to the
Figure 3. Crude weight loss in the NUGENOB trial by rs6014646, rs3746619 (Thr6Lys), rs3827103 (Val81Ile) and rs1543873 MC3R
genotypes. Legend to Figure 3: P-values were calculated from multivariate models (see text).
doi:10.1371/journal.pone.0019934.g003
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the literature supporting a different weight gain/loss pattern in
Mc3r2/2 mice according to the type of diet (high-fat versus low-
fat). Butler et al. [28] described that the food intake of Mc3r2/2
mice is not increased under low-fat or high-fat feeding in
comparison with their wild-type littermates in the context of a
specific genetic background. However, when Mc3r2/2 mice on a
B6 genetic background are fed a high-fat diet, they show
hyperphagia and higher body fat when compared with the wild-
type mouse [28]. On the other hand, a lower respiratory quotient
was observed for Mc3r2/2 mice fed with a low-fat diet compared
to their wild-type littermates [28]. Finally, fatty acid oxidation in
Mc3r2/2 mice exposed to a low-fat diet seems to be reduced
compared to the oxidation of wild-type mice [31].
Although the NUGENOB trial was primarily designed to study
the effect of two diets on weight loss, a secondary goal was the
assessment of genetic effects and interactions between diet and
genes (NUGENOB stands for ‘‘Nutrition, genes and obesity’’)
[32]. Under this framework, the effect of 42 SNPs in 26 candidate
genes were previously assessed in relation to weight loss, finding no
significant associations after multiple testing adjustment [20].
Subsequently, an interaction effect was found between the
diabetes-associated TCF7L genotypes and dietary fat/carbohy-
drate content [33], and also between FTO rs9939609 and
macronutrient diet composition [34]. On the other hand, other
studies indicated that a common variant genetic variation near
MC4R gene (rs17782313), a direct candidate gene for food intake
and obesity, does not seem to have a relevant effect on weight loss
in adults after a lifestyle intervention [35].
Studies in monozygotic twins support the idea that weight loss after
negative energy balance is under genetic control [36]. It is important
to recognize that the study shown herein can be considered as
exploratory, since multiple genetic and environmental factors may
influence weight loss after hypo-energetic diets, making difficult the
detection of consistent genotype-trait associations [22]. One reason
whythe main effectsare sosmall couldbe dueto the smallmagnitude
of weight loss and because the study was based on mixed phenotypes
with different genetic determinants, such as a combination of general
level of obesity with dynamic changes over time. In this context,
longitudinal twin studies with repeated assessment of BMI indicate
that the geneticinfluences on general tracking level ofBMI is different
from those influencing the deviations from the general tracking level,
suggesting that the genes influencing the tendency to become obese
are different from those inducing individual differences in suscepti-
bility to caloric restriction and dietary changes [37]. The difficulty in
finding common genetic variation associated with complex traits is
exemplified in the observational studies on increased BMI in large
genome-wide epidemiological studies. In these studies common
genetic variation seems to explain only a small proportion of BMI z-
score in children or BMI in adults [15,38], with a limited predictive
value for obesity risk [39–40]. It is conceivable that similar weak
effects are present when assessing weight loss after hypo-energetic
diets, even using intervention studies with moderately-large sample
sizes such as the NUGENOB study.
Genetic variants of MC3R have been involved in obesity
development mainly in relation with its role in the control of food
intake [28]. Given that food intake is restricted in the intervention
low-fat and high-fat groups, it was possible that the a priori
hypothesized weight loss differences by MC3R genotype would
have been arisen as a consequence of changes in energy
expenditure. However, we have not found significant genetic
effects on REE by MC3R genotype during the 10-week
intervention trial. Regarding the analysis of food intake, it is also
possible that assuming allocated diet (high-fat or low-fat) instead of
measuring actual diet, has a disturbing effect in finding true
associations, due to lack of compliance of participants with the
energy deficit imposed by hypo-energetic diets. Regarding drop-
out rates, weight loss intervention in the original analysis of the
NUGENOB trial showed increased drop-out rates among
participants randomized to high-fat compared to low-fat diet
[17]. However, we have not found differences in drop-out by
MC3R genotypes, suggesting that the assessment of the role of
MC3R variants on weight loss is not affected by this factor. Finally,
It is also important to mention that the assessment of gene*diet
interactions was hampered by the increased sample size that would
have been required to assess such effect in comparison with the
sample size needed for evaluating main effects.
As a recapitulation, only MC3R rs6014646 achieved nominal
statistical significance under the 0.05 level in relation to weight loss
in adult obese subjects of the NUGENOB trial. However, this
Table 4. MC3R variants, fat mass and resting energy expenditure (REE) change in the NUGENOB trial.
Per-allele* fat mass change (Kg) Per-allele* REE change (kcal/24 h.)
SNP
Beta
coefficient
Standard
error
P-value gene
effects
P-value
gene*diet
interaction
Beta
coefficient
Standard
error
P-value
gene
effects
P-value
gene*diet
interaction
rs6024728 20.04 0.22 0.85 0.43 2.08 14.01 0.88 0.09
rs6014646 20.04 0.18 0.84 0.12 25.18 11.66 0.66 0.09
rs6024730 20.21 0.22 0.34 0.57 211.47 14.11 0.42 0.25
rs6024731 20.18 0.19 0.35 0.65 23.25 12.61 0.78 0.06
rs11697509 20.19 0.26 0.46 0.21 26.95 16.17 0.67 0.05
rs6127698 0.04 0.17 0.82 0.85 1.19 10.79 0.91 0.80
rs3746619 20.37 0.30 0.22 0.90 221.69 19.01 0.25 0.17
rs3827103 20.33 0.31 0.30 0.76 229.31 20.13 0.15 0.16
rs1543873 20.33 0.27 0.23 0.24 226.25 17.04 0.12 0.08
rs6099058 20.18 0.17 0.29 0.59 21.50 10.66 0.89 0.89
*Per-allele changes were calculated using the number of the least frequent alleles for each SNP (coded a 0, 1 or 2 alleles) and under the co-dominant model adjusted for
covariates (see statistical methods). Changes in REE were assessed in a subset of the sample (440 participants).
doi:10.1371/journal.pone.0019934.t004
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multiple testing. Supporting the lack of effect of MC3R genotypes
on anthropometric variables, tables 1 and 3 show point estimations
for the genetic effects on weight loss, fat mass loss, waist and REE
changes that are close to the zero effect, with relatively narrow
confidence intervals. Moreover, no gene*diet interaction effects
were found to be significant. In conclusion, the present study
provided overall sufficient evidence to support that there is no
major effect of genetic variants of MC3R and differential weight
loss after a 10-week dietary intervention with hypo-energetic diets
in obese Europeans.
Acknowledgments
The dietician core group and all other co-workers from the twelve
participating centers are gratefully acknowledged. NUGENOB (‘Nutrient-
Gene interactions in human obesity–implications for dietary guidelines’)
was supported by the European Community. Trial ISRCTN25867281
(Contract QLK1-CT-2000-00618). See www.nugenob.org for a complete
list of NUGENOB contributors.
Author Contributions
Performed the experiments: AA OP WHMS IM JAM TIAS JMO.
Analyzed the data: JLS RDlC CH AM KG CN TH. Contributed
reagents/materials/analysis tools: OP TH CH. Wrote the paper: JLS
TIAS JAM. Conceived the present sudy: JLS JAM. Conceived and
designed the NUGENOB study: TIAS AA OP WHMS.
References
1. Seeley RJ, Drazen DL, Clegg DJ (2004) The critical role of the melanocortin
system in the control of energy intake. Annu Rev Nutr 24: 133–149.
2. Adan RA, Tiesjema B, Hillebrand JJ, la Fleur SE, Kas MJ, et al. (2006) The
MC4 receptor and control of appetite. Br J Pharmacol 149: 815–82.
3. Santos JL, Amador P, Valladares M, Albala C, Martı ´nez JA, et al. (2008)
Obesity and eating behaviour in a three-generation Chilean family with carriers
of the Thrl50Ile mutation in the melanocortin-4 receptor gene. J Physiol
Biochem 64: 205–210.
4. Chen AS, Marsh DJ, Trumbauer ME, Frazier EG, Guan XM, et al. (2000)
Inactivation of the mouse melanocortin-3 receptor results in increased fat mass
and reduced lean body mass. Nat Genet 26: 97–102.
5. Butler AA, Kesterson RA, Khong K, Cullen MJ, Pelleymounter MA, et al.
(2000) A unique metabolic syndrome causes obesity in the melanocortin-3-
receptor-deficient mouse. Endocrinology 141: 3518–3521.
6. Fox CS, Heard-Costa NL, Vasan RS, Murabito JM, D Agostino R, et al. (2005)
Genomewide linkage analysis of weight change in the Framingham Heart Study.
J Clin Endocrinol Metab 90: 3197–3201.
7. Lembertas AV, Pe ´russe L, Chagnon YC, Fisler JS, Warden CH, et al. (1997)
Identification of an obesity quantitative trait locus on mouse chromosome 2 and
evidence of linkage to body fat and insulin on the human homologous region
20q. J Clin Invest 100: 1240–1247.
8. Feng N, Young SF, Aguilera G, Puricelli E, Adler-Wailes DC, et al. (2005) Co-
occurrence of two partially inactivating polymorphisms of MC3R is associated
wih pediatric-onset obesity. Diabetes 54: 2663–2667.
9. Mencarelli M, Walker GE, Maestrini S, Alberti L, Verti B, et al. (2008) Sporadic
mutations in melanocortin receptor 3 in morbid obese individuals. Eur J Hum
Genet 16: 581–586.
10. Calton MA, Ersoy BA, Zhang S, Kane JP, Malloy MJ, et al. (2009) Association
of functionally significant Melanocortin-4 but not Melanocortin-3 receptor
mutations with severe adult obesity in a large North American case-control
study. Hum Mol Genet 18: 1140–1147.
11. Lee Y, Poh L, Kek B, Loke K (2007) The role of melanocortin receptor gene in
childhood obesity. Diabetes 56: 2622–2630.
12. Obrego ´n AM, Amador P, Valladares M, Weisstaub G, Burrows R, et al. (2010)
Melanocortin 3 receptor gene variants: association with childhood obesity and
eating behavior in Chilean families. Nutrition 26: 760–765.
13. Savastano DM, Tanofsky-Kraff M, Han JC, Ning C, Sorg RA, et al. (2009)
Energy intake and energy expenditure among children with polymorphisms of
the melanocortin-3 receptor. Am J Clin Nutr 90: 912–920.
14. Schalin-Ja ¨ntti C, Valli-Jaakola K, Oksanen L, Martelin E, Laitinen K, et al.
(2003) Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes
Relat Metab Disord 27: 70–74.
15. Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P,
et al. (2009) Genome-wide association yields new sequence variants at seven loci
that associate with measures of obesity. Nat Genet 41: 18–24.
16. Santoro N, Perrone L, Cirillo G, Raimondo P, Amato A, et al. (2007) Effect of
the melanocortin-3 receptor C17A and G241A variants on weight loss in
childhood obesity. Am J Clin Nutr 85: 950–953.
17. Petersen M, Taylor MA, Saris WH, Verdich C, Toubro S, et al. (2006)
Randomized, multi-center trial of two hypo-energetic diets in obese subjects:
high- versus low-fat content. In J Obesity 30: 552–560.
18. Weir JB (1949) New methods for calculating metabolic rate with especial
reference to protein metabolism. J Physiol 109: 1–9.
19. Dudbridge F (2008) Likelihood-based association analysis for nuclear families
and unrelated subjects with missing genotype data. Hum Hered 66: 87–98.
20. Sørensen TI, Boutin P, Taylor MA, Larsen LH, Verdich C, et al. (2006) Genetic
polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic
high- versus low-fat diets. PLoS Clin Trials 1: e12.
21. Martinez JA, Parra MD, Santos JL, Moreno-Aliaga MJ, Marti A, et al. (2008)
Genotype-dependent response to energy-restricted diets in obese subjects:
Towards personalized nutrition. Asia Pac J Clin Nutr 17(Suppl 1): 119–122.
22. Moreno-Aliaga MJ, Santos JL, Marti A, Martı ´nez JA (2005) Does weight loss
prognosis depend on genetic make-up? Obesity Rev 6: 155–168.
23. Oswal A, Yeo GSH (2007) The leptin melanocortin pathway and the control of
body weight: lessons from human and murine genetics. Obes Rev 8: 293–306.
24. Garfield AS, Lam DD, Marston OJ, Przydzial MJ, Heisler LK (2009) Role of
central melanocortin pathways in energy homeostasis. Trends Endocrinol Metab
20: 203–215.
25. Rutanen J, Pihlajama ¨ki J, Va ¨nttinen M, Salmenniemi U, Ruotsalainen E, et al.
(2007) Single nucleotide polymorphisms of the melanocortin-3 receptor gene are
associated with substrate oxidation and first-phase insulin secretion in offspring
of type 2 diabetic subjects. J Clin Endocrinol Metab 92: 1112–1117.
26. Marks DL, Hruby V, Brookhart G, Cone RD (2006) The regulation of food
intake by selective stimulation of the type 3 melanocortin receptor (MC3R).
Peptides 27: 259–264.
27. Lee M, Kim A, Conwell IM, Hruby V, Mayorov A, et al. (2008) Effects of
selective modulation of the central melanocortin-3-receptor on food intake and
hypothalamic POMC expression. Peptides 29: 440–447.
28. Butler AA (2006) The melanocortin system and energy balance. Peptides 27:
281–290.
29. Chhajlani V (1996) Distribution of cDNA for melanocortin receptor subtypes in
human tissues. Biochem Mol Biol Int 38: 73–80.
30. Sutton GM, Perez-Tilve D, Nogueiras R, Fang J, Kim JK, et al. (2008) The
melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci
28: 12946–12955.
31. Sutton GM, Trevaskis JL, Hulver MW, McMillan RP, Markward NJ, et al.
(2006) Diet-genotype interactions in the development of the obese, insulin-
resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors.
Endocrinology 147: 2183–2196.
32. Santos JL, Boutin P, Verdich C, Holst C, Larsen LH, et al. (2006) Genotype-by-
nutrient interactions assessed in European obese women: a case-only study.
Eur J Nutr 59: 1–10.
33. Grau K, Cauchi S, Holst C, Astrup A, Martinez JA, et al. (2010) TCF7L2
rs7903146-macronutrient interaction in obese individuals’ responses to a 10-wk
randomized hypoenergetic diet. Am J Clin Nutr 91: 472–479.
34. Grau K, Hansen T, Holst C, Astrup A, Saris WHM, et al. (2009)
Macronutrient-specific effect of FTO rs9939609 in response to a 10-week
randomized hypo-energetic diet among obese Europeans. Int J Obes 33:
1227–1234.
35. Haupt A, Thamer C, Heni M, Tschritter O, Machann J, et al. (2009) Impact of
variation near MC4R on whole-body fat distribution, liver fat, and weight loss.
Obesity 17: 1942–1495.
36. Hainer V, Stunkard AJ, Kunesova ´ M, Parı ´zkova ´ J, Stich V, et al. (2000)
Intrapair resemblance in very low calorie diet-induced weight loss in female
obese identical twins. Int J Obes Relat Metab Disord 24: 1051–1507.
37. Hjelmborg JB, Fagnani C, Silventoinen K, McGue M, Korkeila M, et al. (2008)
Genetic influences on growth traits of BMI: a longitudinal study of adult twins.
Obesity 16: 847–852.
38. Zhao J, Bradfield JP, Li M, Wang K, Zhang H, et al. (2009) The role of obesity-
associated loci identified in genome-wide association studies in the determination
of pediatric BMI. Obesity 17: 2254–2257.
39. Sandholt CH, Sparsø T, Grarup N, Albrechtsen A, Almind K, et al. (2010)
Combined analyses of 20 common obesity susceptibility variants. Diabetes 59:
1667–1673.
40. Li S, Zhao JH, Luan J, Luben RN, Rodwell SA, et al. (2010) Cumulative effects
and predictive value of common obesity-susceptibility variants identified by
genome-wide association studies. Am J Clin Nutr 91: 184–190.
MC3R Genetic Variants and Weight Loss in Obesity
PLoS ONE | www.plosone.org 8 June 2011 | Volume 6 | Issue 6 | e19934